BCM
KZR

Bridgeway Capital Management’s Kezar Life Sciences KZR Stock Holding History

Bridgeway Capital Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-51,638
Closed -$325K – 1279
2025
Q4 		$325K Buy
51,638
+10,638
+26% +$62K 0.01% 915
2025
Q3 		$160K Hold
41,000
– – ﹤0.01% 1049
2025
Q2 		$188K Hold
41,000
– – ﹤0.01% 973
2025
Q1 		$200K Buy
+41,000
New +$249K 0.01% 928
2024
Q4 		– Sell
-1,160
Closed -$8.97K – 1255
2024
Q3 		$8.97K Sell
1,160
-9,700
-89% -$58.5K ﹤0.01% 1250
2024
Q2 		$65.2K Hold
10,860
– – ﹤0.01% 1200
2024
Q1 		$97.9K Sell
10,860
-5,000
-32% -$45.5K ﹤0.01% 1210
2023
Q4 		$150K Sell
15,860
-15,150
-49% -$133K ﹤0.01% 1186
2023
Q3 		$369K Buy
31,010
+11,460
+59% +$203K 0.01% 964
2023
Q2 		$479K Buy
+19,550
New +$509K 0.01% 915
2022
Q3 		– Sell
-2,720
Closed -$225K – 1427
2022
Q2 		$225K Hold
2,720
– – 0.01% 1066
2022
Q1 		$452K Sell
2,720
-11,540
-81% -$1.66M 0.01% 963
2021
Q4 		$2.38M Sell
14,260
-5,760
-29% -$650K 0.04% 554
2021
Q3 		$1.73M Sell
20,020
-2,500
-11% -$165K 0.03% 678
2021
Q2 		$1.22M Sell
22,520
-1,000
-4% -$56.8K 0.02% 789
2021
Q1 		$1.4M Buy
+23,520
New +$1.37M 0.03% 746
2020
Q2 		– Sell
-4,997
Closed -$218K – 1354
2020
Q1 		$218K Sell
4,997
-2,820
-36% -$115K 0.01% 1031
2019
Q4 		$313K Buy
7,817
+3,637
+87% +$112K ﹤0.01% 1106
2019
Q3 		$137K Buy
+4,180
New +$202K ﹤0.01% 1222

Other funds holding KZR

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.36% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Bridgeway Capital Management's KZR Position: Q1 2026 in Review

Bridgeway Capital Management sold out of Kezar Life Sciences (KZR) in Q1 2026, closing a stake of 51,638 shares — an estimated $325K sold.

Bridgeway Capital Management first reported a position in KZR in Q3 2019 and held it in 19 quarters. The position peaked at $2.38M in Q4 2021. 43 funds tracked by Wall St. Rank hold KZR as of Q1 2026.

  • Bridgeway Capital Management reported no remaining Kezar Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Bridgeway Capital Management sold 51,638 Kezar Life Sciences shares in Q1 2026, an estimated $325K.
  • Bridgeway Capital Management first reported a position in Kezar Life Sciences in Q3 2019 and held it in 19 quarters.
  • Bridgeway Capital Management's Kezar Life Sciences position peaked at $2.38M in Q4 2021.
  • 43 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.